Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Hic1 in the maintenance of lung CD4+ T cells (TRM) in allergic asthma

EF 2023-24

Résumé
Asthma is a long-lasting lung disease that impact 300 million individuals worldwide. The condition is characterized by lung inflammation, overproduction of mucus, and narrowed airways, primarily caused by a specific group of immune cells known as CD4+ T helper (TH) cells. Recent research highlights the critical role of a subset of these TH cells, termed tissue-resident memory T cells (TRM), found in the lungs of individuals with asthma. These TRM cells are pivotal in recurring asthma episodes as they quickly react to allergens, distinguishing them from other memory T cells circulating in the body. Developing therapies focusing on TRM cells presents a promising avenue for asthma treatment, aiming to diminish the swift allergenic responses initiated by these cells. A key player in this process is a molecule named Hic1, prevalent in TRM cells and responsible for regulating gene activity within cells. Hic1 helps inactivate various cells and influences the residence of TRM cells in many tissues. We hypothesize that Hic1 is vital in supporting the TRM cells in the lungs, and the absence of Hic1 may lead to the reduction of TRM cells, potentially abolishing the responses to allergens. This research could set a foundation for potential treatments for asthma and other diseases in which TRM cells play a crucial role. In summary, delving deeper into the functions of TRM cells and the Hic1 molecule could pave the way for innovative asthma and TRM-dependent disease treatments, fostering hope for enhanced disease management.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506152
Name
Kim Taehyun
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Hic1 in the maintenance of lung CD4+ T cells (TRM) in allergic asthma
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Asthma; Biomedical Engineering; Drug Therapy; Genetic Engineering; Hic1; Immunoengineering; Immunology; Tissue Residence
Abstract
Asthma is a long-lasting lung disease that impact 300 million individuals worldwide. The condition is characterized by lung inflammation, overproduction of mucus, and narrowed airways, primarily caused by a specific group of immune cells known as CD4+ T helper (TH) cells. Recent research highlights the critical role of a subset of these TH cells, termed tissue-resident memory T cells (TRM), found in the lungs of individuals with asthma. These TRM cells are pivotal in recurring asthma episodes as they quickly react to allergens, distinguishing them from other memory T cells circulating in the body. Developing therapies focusing on TRM cells presents a promising avenue for asthma treatment, aiming to diminish the swift allergenic responses initiated by these cells. A key player in this process is a molecule named Hic1, prevalent in TRM cells and responsible for regulating gene activity within cells. Hic1 helps inactivate various cells and influences the residence of TRM cells in many tissues. We hypothesize that Hic1 is vital in supporting the TRM cells in the lungs, and the absence of Hic1 may lead to the reduction of TRM cells, potentially abolishing the responses to allergens. This research could set a foundation for potential treatments for asthma and other diseases in which TRM cells play a crucial role. In summary, delving deeper into the functions of TRM cells and the Hic1 molecule could pave the way for innovative asthma and TRM-dependent disease treatments, fostering hope for enhanced disease management.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kim, Taehyun
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~